...
首页> 外文期刊>Lipids in Health Disease >Hydroalcoholic extract of Achillea millefolium improved blood glucose, liver enzymes and lipid profile compared to metformin in streptozotocin-induced diabetic rats
【24h】

Hydroalcoholic extract of Achillea millefolium improved blood glucose, liver enzymes and lipid profile compared to metformin in streptozotocin-induced diabetic rats

机译:Achillea米尔美容改善血糖,肝酶和脂质分布的水醇提取物与链脲佐菌素诱导的糖尿病大鼠二甲双胍相比

获取原文

摘要

Recent studies have reported that herbal extracts may have some protective effect against the complications of diabetes mellitus. This study aimed to investigate the effects of Achillea millefolium hydroalcoholic extract in comparison to metformin on liver damage, lipid abnormality, and glycemic control in diabetic rats. Rats were randomly assigned to 7 groups of 10 animals. Diabetes was induced by injection of streptozotocin (STZ) to 4 groups of rats. Three groups of diabetic rats were given 250?mg/kg/day metformin, 25?mg/kg/day Achillea millefolium hydroalcoholic extract, or 100?mg/kg/day of this extract. Two non-diabetic groups were also given either 25?mg/kg/day or 100?mg/kg/day Achillea millefolium extract. Normal control and diabetic control rats received 1?mL/day of normal saline. Treatments were administered through oral gavage for 28?days. At the end, rats were anesthetized with ether and their serum samples were separated in order to measure blood glucose, serum total protein, lipids, and liver enzymes. There was a significant reduction in blood glucose, serum liver enzymes, triglycerides, and total- and LDL-cholesterol levels of the Achillea millefolium extract-treated groups compared to the other groups. In addition, there was a significant increment in body weight and HDL-cholesterol serum level in the Achillea millefolium-treated groups. Achillea millefolium extract compared to metformin reduces lipid abnormality, blood glucose and liver enzymes in STZ-induced diabetic rats. Future clinical studies are warranted to confirm our experimental findings in humans.
机译:最近的研究报告说,草药提取物可能对糖尿病并发症具有一些保护作用。本研究旨在探讨Achillea Millefolium醇醇提取物与二甲双胍对糖尿病大鼠肝损伤,脂质异常和血糖对照的影响。大鼠随机分配给7组10只动物。通过注射链脲佐菌素(STZ)至4组大鼠诱导糖尿病。给出了三组糖尿病大鼠250〜Mg / kg /天二甲酚,25μlm×mg / kg / day achillea米尔氟醇水醇提取物,或提取100μmg/ kg /天。还给出了两个非糖尿病族,也给出了25μlmg/ kg /天或100μmβmg/ kg / day achillea米洛米醇提取物。正常对照和糖尿病对照大鼠接受1?ml /天的生理盐水。通过口服饲喂治疗28?天。最后,用乙醚麻醉大鼠,并分离它们的血清样品以测量血糖,血清总蛋白质,脂质和肝酶。与其他基团相比,血糖,血清肝酶,甘油三酯和总和和LDL-胆固醇水平的总和和LDL-胆固醇水平。此外,Achillea Millefolium治疗组中体重和HDL-胆固醇血清水平具有显着增加。阿基勒亚米尔美容提取物与二甲双胍相比减少了STZ诱导糖尿病大鼠的脂质异常,血糖和肝酶。未来的临床研究是有必要确认我们在人类的实验结果。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号